Skip to Main content Skip to Navigation
Journal articles

Management of dyslipidaemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-up.

Abstract : Reduction of LDL-cholesterol (LDLc) is essential to decrease the cardiovascular mortality in rheumatoid arthritis (RA). Between 2005 and 2010, French recommendations for dyslipidaemia defined the LDLc target based on the number of cardiovascular risk factors. In 2006, it was recommended to consider LDLc objectives with RA being counted as an additional cardiovascular risk factor. Our objective was to assess lipid target achievement between 2006 and 2010 in a cohort of patients with recent-onset RA.
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-02880479
Contributor : Anne-Christine Rat <>
Submitted on : Thursday, June 25, 2020 - 9:23:07 AM
Last modification on : Friday, June 26, 2020 - 3:33:34 AM

Identifiers

  • HAL Id : hal-02880479, version 1
  • PUBMED : 28079508

Citation

Anne Tournadre, Bruno Pereira, Jean-Jacques Dubost, Nathalie Rincheval, Anne Christine Rat, et al.. Management of dyslipidaemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-up.. Clinical and experimental rheumatology, Clinical and Experimental Rheumatology Sas, 1970, 35 (2), pp.296-302. ⟨hal-02880479⟩

Share

Metrics

Record views

5